Ara-290

Ara-290

$50.00

Scientific Name: Cibinetide
Alternative Names: ARA290, PHBSP, PH-BSP
CAS #: 1208243-50-8
Molecular Formula: C₅₁H₈₄N₁₆O₂₁
Molecular Weight (M.W.): Approximately 1257.3 g/mol
Sequence: Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH
One-Letter Sequence: XEQLERALNSS
Length: 11 amino-acid residues
Product Type: Synthetic Modified Research Peptide

ARA-290, also known as Cibinetide, is a synthetic 11-residue peptide supplied for controlled laboratory and analytical research.

Its defined molecular structure begins with an N-terminal pyroglutamyl residue, represented by Pyr or Glp, followed by a specific peptide sequence. This terminal modification forms part of the compound’s chemical identity and should be retained in accurate technical documentation.

ARA-290 may be examined in controlled non-clinical studies involving peptide characterization, receptor-associated biochemical systems, molecular interactions, structure-function analysis, and comparative analytical research.

Research Applications

ARA-290 may be examined in controlled research environments involving:

  • Modified peptide characterization
  • Ligand-receptor interaction studies
  • Molecular signaling research
  • Structure-function analysis
  • Peptide stability assessment
  • Analytical peptide comparison
  • Non-clinical biochemical models
  • Cellular research systems

Any experimental observations should remain specific to the applicable study design and should not be interpreted as evidence of therapeutic efficacy, neurological benefit, tissue protection, clinical effectiveness, or suitability for human use.

Structural Information

ARA-290 is commonly represented as:

H-Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH

PubChem sequence representation:

XEQLERALNSS

Here, the initial X represents the modified pyroglutamyl residue rather than a conventional unmodified amino acid.

The N-terminal pyroglutamate is an important part of the molecule’s defined identity and should be included in analytical documentation.

Analytical Identification

Relevant analytical characterization may include:

  • Peptide identity confirmation
  • Sequence verification
  • N-terminal pyroglutamate characterization
  • Molecular mass assessment
  • Chromatographic purity testing
  • Structural analysis
  • Lot-specific quality testing

If supplied as an acetate, TFA, or another salt/counter-ion form, the molecular formula and molecular weight may differ from the parent form.

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Compound identity
  • Amino-acid sequence
  • N-terminal modification
  • Molecular formula
  • Molecular weight
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific analytical documentation should take precedence over generalized vendor information.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for research materials.

Research Use Only

ARA-290 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, neurological use, tissue-protection use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, neurological, regenerative, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.

RELATED PRODUCTS